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hydroxybutyrate against the 
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The bacterial storage compound poly-β-hydroxybutyrate, a polymer of the short-chain fatty acid 
3-hydroxybutyrate, has been reported to protect various aquatic animals from bacterial disease. In 
order to obtain a better mechanistic insight, we aimed to (1) investigate whether 3-hydroxybutyrate 
is released from poly-β-hydroxybutyrate within sterile brine shrimp larvae, (2) determine the impact 
of 3-hydroxybutyrate on the virulence of Vibrio campbellii to brine shrimp larvae and on its cell density 
in the shrimp, and (3) determine the impact of this compound on virulence factor production in the 
pathogen. We detected 3-hydroxybutyrate in poly-β-hydroxybutyrate-fed brine shrimp, resulting in 
24 mM 3-hydroxybutyrate in the intestinal tract of shrimp reared in the presence of 1000 mg l−1 poly-β-
hydroxybutyrate. We further demonstrate that this concentration of 3-hydroxybutyrate does not affect 
the growth of V. campbellii, whereas it decreases the production of different virulence factors, including 
hemolysin, phospholipase and protease activities, and swimming motility. We hypothesize that by 
affecting all these virulence factors at once, 3-hydroxybutyrate (and thus also poly-β-hydroxybutyrate) 
can exert a significant impact on the virulence of V. campbellii. This hypothesis was confirmed in a 
challenge test showing that 3-hydroxybutyrate protected gnotobiotic brine shrimp from pathogenic  
V. campbellii, without affecting the number of host-associated vibrios.
Aquaculture is playing an increasingly important role with respect to food security, and the sector is predicted to 
dominate aquatic food supply within a few years1. However, the further sustainable expansion of the aquaculture 
sector is currently hampered by a number of factors, amongst which diseases are playing a prominent role, espe-
cially in the early life stages of the animals2. Vibrios belonging to the Harveyi clade (such as Vibrio campbellii) are 
amongst the major pathogens of marine organisms3. These bacteria cause huge losses in the aquaculture industry 
worldwide, with acute hepatopancreatic necrosis disease (AHPND) as a notable recent example4,5. Global losses 
in the shrimp farming industry due to this disease have been estimated to be over US$ 1 billion per year during 
the last eight years6. The wide and frequent use of antibiotics has resulted in the development and spread of 
(multiple) antibiotic resistance in aquaculture pathogens, rendering antibiotics ineffective in treating bacterial 
diseases7. Moreover, public opinion currently distrusts the use of antibiotics in food production8, and therefore, 
alternatives to antibiotics are needed in order to enable the aquaculture sector to further expand in a sustainable 
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way. One of the strategies that is currently receiving significant attention in the field, is antivirulence therapy – the 
inhibition of virulence, rather than growth, of bacterial pathogens9.
Short-chain fatty acids are able to inhibit the growth of various bacteria, and as a consequence, there is interest 
in the use of these compounds as biocontrol agents in animal production10. These compounds are also able to 
protect aquatic animals from vibriosis11. However, because of dilution in the aquatic environment, the effec-
tive doses need to be high, rendering short-chain fatty acids economically less attractive for disease control in 
aquaculture12. In order to overcome this limitation, we have used the insoluble bacterial storage compound 
poly-β-hydroxybutyrate, a polymer of the short-chain fatty acid 3-hydroxybutyrate, as a source of short-chain 
fatty acids13. Abiotic decomposition of poly-β-hydroxybutyrate is a relatively slow process under mild con-
ditions and the degradation rate is affected by factors such as pH and temperature12. Poly-β-hydroxybutyrate 
can be degraded in the gastrointestinal tract of animals. Indeed, Freier et al. reported that digestive enzymes 
increased the decomposition of poly-β-hydroxybutyrate threefold in phosphate buffer14. Forni et al. reported 
that untreated poly(β-hydroxybutyrate-co-β-hydroxyvalerate) copolymer was poorly digested in pigs15. However, 
poly-β-hydroxybutyrate is most efficiently degraded by poly-β-hydroxybutyrate depolymerase enzymes pro-
duced by various micro-organisms, and this enzyme activity also results in an improved protective effect of 
poly-β-hydroxybutyrate against vibriosis in aquatic animals16.
We have previously demonstrated that the addition of poly-β-hydroxybutyrate to the rearing water offers 
protection against V. campbellii in a model system with brine shrimp larvae13. Later research revealed that 
poly-β-hydroxybutyrate improved the survival of various aquaculture species, including finfish, crustaceans as 
well as mollusks17–22. Poly-β-hydroxybutyrate is water-insoluble, and therefore, we hypothesized that in order 
to exert a beneficial effect, the polymer must be degraded into water-soluble products (e.g. 3-hydroxybutyrate 
monomers) in the intestinal tract, and that these water-soluble products are responsible for the beneficial 
effect12. This hypothesis was based on indirect observations because thus far, the release of 3-hydroxybutyrate in 
poly-β-hydroxybutyrate-fed animals has not been demonstrated.
Short-chain fatty acids, including 3-hydroxybutyrate, are capable of inhibiting the growth of vibrios belong-
ing to the Harveyi clade in a pH-dependent manner, with effective concentrations within the range of 10–100 
mM11,13. The pH-dependence of the effect is due to the fact that the short-chain fatty acids can only pass through 
the cell membranes of bacteria in their undissociated form10, which is more prevalent at lower pH (according to 
the Henderson-Hasselbach equation). Once inside the cytoplasm, the short-chain fatty acids dissociate, thereby 
increasing the intracellular concentration of protons23. This is thought to be the reason for the growth-inhibitory 
effect of short-chain fatty acids because the cells need to spend energy in order to maintain the intracellular pH at 
the optimal level and thus cannot use this energy for other metabolic processes10. Because short-chain fatty acids 
are thought to interfere with the energy resources of bacteria, a stronger growth-inhibitory effect is expected in 
nutrient-poor environments than in nutrient-rich environments (where energy resources are more abundant). 
Remarkably, we previously found that short-chain fatty acids (including 3-hydroxybutyrate) protect gnotobi-
otic brine shrimp from V. campbellii at concentrations that are below the growth-inhibitory concentration11,13. 
One possible explanation for this observation might be that sub-growth-inhibitory concentrations of short-chain 
fatty acids decrease virulence gene expression in the pathogen, and in this way prevent it from infecting the 
host12. Indeed, short-chain fatty acids have been shown before to decrease virulence factor production in enteric 
pathogens such as Salmonella enterica and Shiga toxin-producing Escherichia coli24–26. However, the impact of 
3-hydroxybutyrate on virulence factor production in vibrios is currently unknown.
In order to obtain a better insight into the protective mechanism of poly-β-hydroxybutyrate, in this study, 
we aimed at investigating the release of 3-hydroxybutyrate from poly-β-hydroxybutyrate in sterile brine shrimp 
larvae, to determine the impact of subinhibitory concentrations of 3-hydroxybutyrate that are representative of 
those released from poly-β-hydroxybutyrate in the host, on virulence factor production by V. campbellii, and 
to determine the impact of 3-hydroxybutyrate on the virulence of the pathogen to brine shrimp and on its cell 
density in the brine shrimp.
Results
Determination of 3-hydroxybutyrate levels in poly-β-hydroxybutyrate-fed brine shrimp larvae. 
We previously hypothesised that the beneficial activity of poly-β-hydroxybutyrate is mediated by the release of 
water-soluble 3-hydroxybutyrate monomers12. In order to investigate this, we set-up sterile brine shrimp cultures 
with different concentrations of poly-β-hydroxybutyrate particles added to the rearing water, and then deter-
mined the concentration of 3-hydroxybutyrate in brine shrimp larvae harvested after 24 h. The concentration 
of 3-hydroxybutyrate in the brine shrimp samples increased with increasing doses of poly-β-hydroxybutyrate 
in the rearing water (Table 1). The 3-hydroxybutyrate concentrations in samples from the 100 and 1000 mg l−1 
poly-β-hydroxybutyrate treatments were significantly different from those in samples taken from brine shrimp 
cultures that had not received poly-β-hydroxybutyrate. Assuming that all 3-hydroxybutyrate originated from the 
intestinal tracts of the sampled larvae, we further calculated the concentration of 3-hydroxybutyrate in the brine 
shrimp gut, and found that 3-hydroxybutyrate concentrations increased to 24 mM in the presence of 1000 mg l−1 
poly-β-hydroxybutyrate (Table 1).
Impact of 3-hydroxybutyrate on the growth of Vibrio campbellii. We investigated the impact of 
3-hydroxybutyrate on the growth of V. campbellii in both nutrient-rich and nutrient-poor conditions, and at 
pH 6 or 7. At pH 6, the growth of V. campbellii was inhibited at the highest concentration of 3-hydroxybutyrate 
(125 mM), with a significantly longer lag phase in nutrient-rich conditions and a complete inhibition of growth in 
nutrient-poor conditions (Fig. 1A and C). At pH7, on the other hand, only a relatively small effect was observed 
at 125 mM 3-hydroxybutyrate, both in nutrient-rich and nutrient-poor conditions (Fig. 1B and D).
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Impact of 3-hydroxybutyrate on the survival of brine shrimp larvae challenged with Vibrio 
campbellii and on the cell density of shrimp-associated vibrios. In a further experiment, we deter-
mined the impact of 25 or 125 mM 3-hydroxybutyrate on the virulence of V. campbellii in a standardised model 
system with gnotobiotic brine shrimp larvae. We have previously demonstrated that the addition of 1000 mg l−1 
poly-β-hydroxybutyrate to the rearing water offers protection against V. campbellii in this model system13. Brine 
shrimp larvae are particle filter feeders that are unable to accumulate dissolved compounds27 and therefore, the 
concentration of 3-hydroxybutyrate within the brine shrimp larvae is expected to be the same as the concen-
tration in the rearing water. Larvae challenged with V. campbellii showed a significantly higher survival in the 
presence of both concentrations of 3-hydroxybutyrate, and the survival of challenged larvae in the presence of 
3-hydroxybutyrate was not significantly different from that of unchallenged larvae (Fig. 2A). We also observed 
that the survival of non-challenged larvae was higher in the presence of 3-hydroxybutyrate, suggesting a direct 
beneficial effect on the brine shrimp. Finally, we determined the numbers of V. campbellii that were associated 
with the brine shrimp larvae and found that there were no significant differences between treatments (Fig. 2B).
Impact of 3-hydroxybutyrate on virulence factor production by Vibrio campbellii. We deter-
mined the impact of non-growth inhibitory concentrations of 3-hydroxybutyrate on the production of hemo-
lytic, lipase, phospholipase and protease activities in V. campbellii. Hemolytic activity decreased at 1 mM 
of 3-hydroxybutyrate or more, with a maximal decrease of 28 and 18% at pH 6 and 7, respectively (Fig. 3A). 
Lipase activity was not affected by 3-hydroxybutyrate (Fig. 3B). Phospholipase activity decreased in the presence 
of 25 mM 3-hydroxybutyrate at pH6 and in the presence of 125 mM at pH 7 (Fig. 3C). Protease activity was 
decreased only at pH 7, with a 26% decrease in the presence of 25 mM 3-hydroxybutyrate, and no clearing zone 
extending beyond the colony diameter in the presence of 125 mM 3-hydroxybutyrate (Fig. 3D). Swimming motil-
ity decreased by 16% in the presence of 25 mM 3-hydroxybutyrate at pH 6, and by 41% in the presence of 125 mM 
[PHB] added (mg l−1)
[3HB] in samples 
(µg ml−1)
Estimated [3HB] in the 
gut (mM)
0 12 ± 5 9 ± 4
10 16 ± 1 11 ± 1
100 24 ± 0* 17 ± 0
1000 35 ± 4* 24 ± 3
Table 1. Concentration of 3-hydroxybutyrate (3HB) in sterile brine shrimp (Artemia franciscana) samples that 
received different concentrations of poly-3-hydroxybutyrate (PHB) in the rearing water (average ± standard 
deviation of 3 replicates). The concentrations of 3HB in the brine shrimp gut were calculated as described 
in Materials and Methods. Asterisks indicate significantly higher concentrations than in the 0 mg l−1 PHB 
treatment (*: P < 0.05).
Figure 1. Growth of Vibrio campbellii ATCC BAA-1116 in nutrient-rich (panels A and B) and nutrient-
poor (panels C and D) media at pH 6 (panels A and C) or pH 7 (panels B and D) in the presence of different 
concentrations of 3-hydroxybutyrate. The error bars represent the standard deviation of three replicates.
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3-hydroxybutyrate at pH 7 (Fig. 4A). Finally, there was no impact of 3-hydroxybutyrate on biofilm formation and 
exopolysaccharide production at any of the concentrations tested (Fig. 4B and C).
Discussion
During recent years, research has revealed that the bacterial storage compound poly-β-hydroxybutyrate, a pol-
ymer of the short-chain fatty acid 3-hydroxybutyrate, is able to improve the survival of various aquaculture 
species13,17–22. Because poly-β-hydroxybutyrate is water-insoluble, we have hypothesized that in order to exert a 
Figure 2. (A) Survival of gnotobiotic brine shrimp (Artemia franciscana) larvae after 2 days of incubation with 
or without 3-hydroxybutyrate and with or without Vibrio campbellii ATCC BAA-1116 challenge. (B) Density 
of Vibrio campbellii ATCC BAA-1116 associated with live brine shrimp larvae at the end of the challenge test. 
Error bars represent the standard error of four shrimp cultures. Bars with a different superscript letter are 
significantly different from each other (One way ANOVA with Duncan’s posthoc test, P < 0.01).
Figure 3. Hemolytic (panel A), lipase (panel B), phospholipase (panel C) and protease (panel D) activities of 
Vibrio campbellii ATCC BAA-1116 in the presence of different concentrations of 3-hydroxybutyrate (0, 1, 5, 
25 and 125 mM, respectively), at pH 6 and 7. The activities without 3-hydroxybutyrate were set at 100% and all 
other treatments were normalized accordingly. Error bars represent the standard deviation of three replicates. 
Asterisks indicate significant differences with the treatment without 3-hydroxybuturate (P < 0.05). Treatment 
with 125 mM 3-hydroxybutyrate was not tested at pH 6.
www.nature.com/scientificreports/
5Scientific REPORTS |  (2018) 8:7245  | DOI:10.1038/s41598-018-25385-w
beneficial effect, the polymer must be degraded into water-soluble products (e.g. 3-hydroxybutyrate monomers) 
in the intestinal tract of aquatic animals, and that these water-soluble products are responsible for the beneficial 
effect12. This hypothesis was based on indirect observations including (1) increased survival of sterile starved 
brine shrimp in the presence of poly-β-hydroxybutyrate, (2) an improved effect of poly-β-hydroxybutyrate in 
the presence of poly-β-hydroxybutyrate-degrading bacteria, and (3) a decreased intestinal pH in sterile sea bass 
larvae receiving poly-β-hydroxybutyrate in their diet13,16,28. In this study, we demonstrate for the first time that 
3-hydroxybutyrate is indeed released in poly-β-hydroxybutyrate-fed animals. Importantly, we used sterile brine 
shrimp for this experiment, excluding the possibility that the release of 3-hydroxybutyrate is a result of bacterial 
poly-β-hydroxybutyrate depolymerase activity. Therefore, the release of 3-hydroxybutyrate must be a result of abi-
otic decomposition and/or enzyme activity in the larvae. Abiotic decomposition in the rearing water is unlikely 
to explain the (relatively high) levels of 3-hydroxybutyrate we measured in the shrimp samples since the abiotic 
release of 3-hydroxybutyrate from poly-β-hydroxybutyrate in aqueous solutions is very limited. For instance, 
Freier et al. reported that less than 5% of PHB decomposed abiotically in phosphate buffer at 37 °C after 4 weeks14. 
A similar decomposition rate would have resulted in 3-hydroxybutyrate concentrations in the brine shrimp rear-
ing water below 2, 20 and 200 µg l−1 for the 10, 100 and 1000 mg l−1 poly-β-hydroxybutyrate treatments, respec-
tively, at the time of taking our samples. Because brine shrimp are particle filter feeders that are not able to 
accumulate dissolved compounds27, the concentration of dissolved compounds (such as 3-hydroxybutyrate) in 
the shrimp body will be the same as in the water. This means that the 3-hydroxybutyrate concentration resulting 
from abiotic decomposition in the rearing water would have resulted in concentrations in the shrimp that are 
lower than 2, 20 and 200 µg l−1. This is more than 175 times lower than the concentrations we measured in our 
samples. Previous research has also shown that poly-β-hydroxybutyrate decomposes in the digestive tract of ani-
mals15 and that digestive enzymes increase the abiotic decomposition of the compound14.
Figure 4. Motility (panel A), biofilm formation (panel B) and exopolysaccharide production (panel C) of Vibrio 
campbellii ATCC BAA-1116 in the presence of different concentrations of 3-hydroxybutyrate, at pH6 or pH7. 
Error bars represent the standard deviation of three replicates. Bars that are significantly different from the 
treatment without 3-hydroxybutyrate are marked with an asterisk (P < 0.05). NT: Not Tested.
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We calculated that the 3-hydroxybutyrate concentration in the gut of brine shrimp larvae reared in the pres-
ence of 1000 mg l−1 poly-β-hydroxybutyrate, increased to 24 mM. This concentration is within the range of con-
centrations of short-chain fatty acids (including 3-hydroxybutyrate) that have been shown to increase the survival 
of brine shrimp larvae challenged with V. campbellii LMG 2136311,13, and this was confirmed here for V. camp-
bellii ATCC BAA-1116. The effect we observed here for strain ATCC BAA-1116 (complete protection) was more 
pronounced than what we found previously for strain LMG 2136313, which reflects the fact that strain LMG 21363 
is more virulent than strain ATCC BAA-111629.
In order to obtain a further mechanistic insight into the protective effect of the poly-β-hydroxybutyrate deg-
radation product 3-hydroxybutyrate, we subsequently determined the impact of the compound on the growth 
of V. campbellii, both in nutrient-rich and nutrient-poor conditions, the latter of which might be more relevant 
to the conditions experienced in the rearing water and in a host. We expected that the impact would be stronger 
in nutrient-poor conditions because short-chain fatty acids are thought to interact with the energy balance in 
bacteria10, and since the cellular energy pool is expected to be lower in nutrient-poor conditions. We found that 
3-hydroxybutyrate inhibits the growth of the vibrios in a pH-dependent manner, showing inhibition at 125 mM 
at pH 6 (but not at pH 7), and this effect was indeed more pronounced in nutrient-poor conditions. The effect we 
observed here is similar to what has been reported before for other short-chain fatty acids in vibrios11,13 and other 
Gram-negative bacteria, such as Salmonella spp25.
We previously reported that short-chain fatty acids (including 3-hydroxybutyrate) increased the sur-
vival of brine shrimp larvae challenged with V. campbellii LMG 21363 at concentrations that were below 
the growth-inhibitory concentration11,13, and this was confirmed here for V. campbellii ATCC BAA-1116. 
Furthermore, we showed here that 3-hydroxybutyrate had no effect on the number of vibrios associated with 
the brine shrimp larvae, further indicating that the beneficial effect is not caused by inhibition of the growth 
of the pathogen. Because of this, we hypothesized that the compound might decrease the ability of the vibrios 
to attack their host, and in order to investigate this, we tested the impact of 3-hydroxybutyrate on a number of 
virulence-related phenotypes. We found that 3-hydroxybutyrate could indeed decrease hemolytic, phospholipase 
and protease activities, and swimming motility in V. campbellii. Consistent with this, Kiran et al. recently reported 
that poly-β-hydroxybutyrate degradation products generated by poly-β-hydroxybutyrate depolymerase activity 
of Vibrio sp. PUGSK8 inhibited hemolytic activity and motility of the bacterium, without affecting its growth30. 
Although the degradation products were not identified in the latter study, poly-β-hydroxybutyrate depolymer-
ases usually degrade poly-β-hydroxybutyrate into 3-hydroxybutyrate oligomers or monomers31. Hence, we 
hypothesize that the effect observed for poly-β-hydroxybutyrate-treated Vibrio sp. PUGSK8 was also caused by 
3-hydroxybutyrate. Short-chain fatty acids are considered to affect the energy balance of bacterial cells (leading 
to growth inhibition at a certain concentration)10, and given the fact that the production (and activity) of viru-
lence factors is metabolically costly32,33, we hypothesize that subinhibitory concentrations of 3-hydroxybutyrate 
decrease the cellular energy status to a level at which virulence, but not growth, is decreased, thus exerting a 
non-specific antivirulence effect.
Several putative virulence factors have been proposed in vibrios belonging to the Harveyi clade. These include 
flagellar motility, which enables the pathogens to colonize the host, exopolysaccharides that enable pathogens to 
form biofilms and to attach to host tissues and protect them from the host’s defense system, and lytic enzymes 
that degrade host tissues and enable pathogens to obtain nutrients34. Amongst the most well-known lytic enzymes 
are hemolysins (damaging blood cells), lipases (degrading lipids), phospholipases (degrading phospholipids) and 
proteases (degrading proteins). We previously reported that there is a positive correlation between hemolysin 
and protease expression, and virulence towards brine shrimp larvae35, and that swimming motility is required 
for full virulence of V. campbellii36. Furthermore, hemolytic and phospholipase activity have also been impli-
cated in virulence of strains belonging to the Harveyi clade37,38. Hence, by simultaneously decreasing the pro-
duction of these virulence factors (even though some of the effects were relatively modest), 3-hydroxybutyrate 
(and thus also poly-β-hydroxybutyrate) can exert a significant impact on the overall virulence of V. campbellii 
in the host. Furthermore, Baruah et al. recently reported that poly-β-hydroxybutyrate induces protective innate 
immune responses in gnotobiotic brine shrimp larvae challenged with V. campbellii, including an increase in 
phenoloxidase activity, one of the major innate immune responses of crustaceans39. It would be highly interesting 
to unravel which property of poly-β-hydroxybutyrate is responsible for this effect as it might also be mediated by 
a degradation product of the polymer (such as 3-hydroxybutyrate). Hence, we think that the strong protective 
effect of poly-β-hydroxybutyrate against bacterial infections can be explained by both a decreased virulence of 
the pathogens (caused by the degradation product 3-hydroxybutyrate) and an increased activity of the immune 
system of the host.
In conclusion, our data demonstrated that 3-hydroxybutyrate is released from poly-β-hydroxybutyrate in 
sterile brine shrimp, and that this compound, at subinhibitory concentrations, inhibits several virulence-related 
phenotypes in pathogenic V. campbellii. Together with an induction of immune responses of the host, these data 
explain the protective effect of poly-β-hydroxybutyrate against infections.
Methods
Bacterial growth conditions. V. campbellii ATCC BAA-1116 was routineously grown in Marine Broth 
(Difco Laboratories, Detroit, USA) at 28 °C with shaking (100 rpm). Cell densities were determined spectropho-
tometrically at 600 nm.
Axenic hatching of brine shrimp (Artemia franciscana). All brine shrimp tests were performed with 
high quality hatching cysts of Artemia franciscana (EG® Type, batch 6940, INVE Aquaculture, Baasrode, Belgium). 
Two hundred mg of cysts were hydrated in 18 ml of tap water during 1 h. Sterile cysts and nauplii were obtained 
via decapsulation, adapted from the protocol described previously40. Briefly, 660 µl of NaOH (32%) and 10 ml of 
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NaOCl (50%) were added to the hydrated cyst suspension. The decapsulation was stopped after 2 min by add-
ing 14 ml of Na2S2O3.7H2O (10 g l−1). During the reaction, 0.22 µm filtered aeration was provided. The decapsu-
lated cysts were washed with autoclaved artificial seawater containing 35 g l−1 of Instant Ocean synthetic sea salt 
(Aquarium Systems Inc., Sarrebourg, France). The cysts were resuspended in a 50 ml tube containing 30 ml of auto-
claved artificial seawater and hatched for 30 h on a rotor (4 min−1) at 28 °C with constant illumination (2000 lux).
Determination of 3-hydroxybutyrate levels in poly-β-hydroxybutyrate-fed brine shrimp larvae. 
1000 mg l−1 stock solutions of poly-β-hydroxybutyrate were prepared by dissolving 500 mg sterile 
poly-β-hydroxybutyrate particles (98% poly-β-hydroxybutyrate, 2% poly-β-hydroxyvalerate; average diameter 
25 µm; Goodfellow, Huntingdon, Ireland) into 500 ml of sterile artifical seawater. The suspensions were soni-
cated in a sonicater bath for 30 minutes. Axenic brine shrimp larvae were stocked in Schott bottles containing 
500 ml sterile artificial sea water and mixed with the poly-β-hydroxybutyrate stock suspension to obtain differ-
ent concentrations of poly-β-hydroxybutyrate particles. The bottles were provided with sterile (0.22 µm filtered) 
aeration and incubated for 24 h at 28 °C. Subsequently, the brine shrimp larvae were harvested on a 150 µm sieve 
and washed with distilled water. The bottom of the sieve was dried with paper cloth to remove excess water, and 
350 mg samples of the brine shrimp larvae were transferred into eppendorf tubes, immediately frozen in liquid 
nitrogen and stored at −80 °C until further use. 3-hydroxybutyrate levels in the samples were determined with 
the β-Hydroxybutyrate (Ketone Body) Colorimetric Assay Kit (Cayman Chemicals, USA). Briefly, 1 ml of assay 
buffer (1 metros-HCl, pH 8,5) was added to the brine shrimp samples. The suspensions were mixed for 40 sec-
onds using a vortex mixer (Ultrathurax), and subsequently centrifuged in a table-top centrifuge at 14500 rpm 
for 5 minutes. The supernatants were filtered over 0.22 µm filters and transferred into new eppendorf tubes. The 
3-hydroxybutyrate concentration in the samples were determined as described in the manufacturer’s instructions. 
The 3-hydroxybutyrate concentration in the brine shrimp gut was calculated as follows. Assuming a dry weight 
of 5 µg per brine shrimp larva41, the samples contained approximately 7000 larvae. Further, Gunasekara et al. 
reported that the gut volume of a brine shrimp larva is approximately 0.002 µl42. Therefore, the total gut volume 
in the samples was 14 µl. The 3-hydroxybutyrate in the brine shrimp gut was then calculated assuming that all 
3-hydroxybutyrate that was present in the 1 ml samples originated from the 14 µl total gut volume of the brine 
shrimp larvae used to prepare the samples.
Determination of the impact of 3-hydroxybutyrate on the growth of Vibrio campbellii. V. campbellii 
was grown overnight in Marine Broth on a shaker at 28 °C. Subsequently, the strain was transferred 1:50 (v/v) to 
either undiluted Marine Broth or 50-fold diluted Marine Broth supplemented with salts to reach the same salt 
concentration as in undiluted Marine Broth (denoted nutrient-rich and nutrient-poor conditions, respectively). 
The media were supplemented with β-hydroxybutyrate at different concentrations (0, 1, 5, 25 and 125 mM). The 
pH of all solutions was adjusted to 6 or 7 by adding HCl. After inoculation, the suspensions were incubated at 
28 °C in a static mode. Growth was monitored by measuring the optical density (OD600) during 24 h. Each treat-
ment was performed in triplicate.
Determination of the impact of 3-hydroxybutyrate on hemolytic, lipase, phospholipase and 
protease activities of Vibrio campbellii. Hemolysin, lipase, phospholipase and protease activities were 
determined as described previously43. Hemolytic activity was determined by supplementing Marine agar con-
taining different concentrations of 3-hydroxybutyrate at pH 6 or 7 with 5% defibrinated sheep blood (Oxoid, 
Basingstoke, Hampshire, UK). Lipase activity was tested by adding 1% Tween 80 (Sigma-Aldrich) into marine 
agar containing different concentrations of 3-hydroxybutyrate at pH 6 or 7. Phospholipase activity was assessed 
on Marine agar supplemented with 1% egg yolk emulsion (Sigma – Aldrich), and different concentrations of 
3-hydroxybutyrate at pH 6 or 7. Protease assay plates were prepared by mixing double strength Marine agar 
containing different concentrations of 3-hydroxybutyrate at pH 6 or 7 with 4% skim milk powder (Oxoid, 
Basingstoke, Hampshire, UK), autoclaved separately at 121 °C for 5 minutes to prevent denaturation of the pro-
tein. Clearing (hemolysin and protease) or opalescent (lipase and phospholipase) zones were measured after 3 
days of incubation at 28 °C. The activity zones were divided by the respective colony diameters in order to correct 
for possible differences in growth. In those cases where there was no activity zone extending beyond the colony 
diameter, the activity zone was set equal to the colony diameter because in such case it is not possible to accurately 
determine the activity zone.
Determination of the impact of 3-hydroxybutyrate on biofilm formation and exopolysaccha-
ride production by Vibrio campbellii. Biofilm formation and exopolysaccharide production were deter-
mined as described previously44. A grown culture of V. campbellii in Marine broth at an OD600 of 1 was inoculated 
1:10 (v/v) into Marine Broth containing different concentrations of 3-hydroxybutyrate at pH 6 or 7, and 200 µl 
aliquots of these suspensions were pipetted into the wells of a 96-well plate. Then, the bacteria were allowed to 
adhere and grow without agitation for 24 h at 28 °C. After that, the cultures were removed and the wells were 
washed three times with 300 μl sterile physiological saline (9 g l−1 NaCl) to remove all non-adherent bacteria. The 
remaining attached bacteria were fixed with 150 μl of 99% methanol per well for 20 min, after which the methanol 
was removed and plates were air-dried. Then, biofilms were stained for 15 min with 150 μl of a 1% crystal violet 
solution (Pro-lab Diagnostics, Richmond Hill, ON, Canada) per well. Excess stain was rinsed off by placing the 
plate under running tap water, and washing was continued until the washings were free of the stain. After the 
plates were air dried, the dye bound to the adherent cells was resolubilized with 150 μl of 95% ethanol per well, 
and absorbance was measured at 570 nm. Sterile medium served as negative control. For the quantification of 
exopolysaccharides, Calcofluor white staining (Sigma-Aldrich) was used. In brief, wells were rinsed after 24 h 
biofilm formation and 100 μl phosphate buffered saline containing 0.5 μl 5 mM Calcofluor white staining dye 
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was added to the wells. After 60 min, fluorescence (excitation 405 nm and emission 500 nm) was measured with 
a Tecan Infinite M200 multi-reader.
Determination of the impact of 3-hydroxybutyrate on swimming motility of Vibrio campbellii. 
Swimming motility assays were performed on soft agar (Marine Broth containing 0.2% agar) containing different 
concentrations of 3-hydroxybutyrate (0, 1, 5, 25 and 125 mM) and at pH6 or pH7, as described previously36. V. 
campbellii was grown overnight in Marine Broth, and 5 µl of the culture was spotted in the center of the soft agar 
plates. Plates were incubated for 24 hours, after which the diameters of the motility halos were measured. All 
assays were done in triplicate.
Brine shrimp challenge test. Challenge tests were performed as described previously45. Briefly, after hatch-
ing, groups of 20 nauplii were transferred to new sterile 50 ml tubes that contained 20 ml of autoclaved artificial 
seawater with different concentrations of 3-hydroxybutyrate (0, 25 and 125 mM, respectively) (Sigma-Aldrich, 
Bornem, Belgium) and set at pH7. The animals were fed with Aeromonas sp. LVS3 at 107 cells ml−1, and for the 
challenge treatments, tubes were inoculated with V. campbellii at 107 cells ml−1. Subsequently, the falcon tubes 
were put back on the rotor and kept at 28 °C, and survival was scored after 2 days. All manipulations were done 
under a laminar flow hood in order to maintain sterility. Each treatment was done in triplicate.
Quantification of brine shrimp-associated vibrios. Bacterial numbers associated with brine shrimp 
larvae were determined as described previously45. Briefly, rinsed larvae were homogenised with a pestle and sharp 
sand, followed by 1 min of bead beating. The homogenised samples were serially diluted and spread-plated on 
Marine agar.
Statistics. Data analysis was carried out using the SPSS statistical software (version 15). Unless stated other-
wise, all other data were compared with independent samples t-tests.
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